Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 964838, 11 pages
http://dx.doi.org/10.1155/2015/964838
Research Article

Oxygen-Loaded Nanodroplets Effectively Abrogate Hypoxia Dysregulating Effects on Secretion of MMP-9 and TIMP-1 by Human Monocytes

1Dipartimento di Oncologia, Università di Torino, 10126 Torino, Italy
2Istituto Nazionale di Ricerca Metrologica (INRIM), 10135 Torino, Italy
3Dipartimento di Neuroscienze, Università di Torino, 10125 Torino, Italy
4Dipartimento di Scienze della Salute, Università di Milano Bicocca, 20900 Monza, Italy
5Dipartimento di Scienza e Tecnologia del Farmaco, Università di Torino, 10125 Torino, Italy
6Dipartimento di Scienze della Sanità Pubblica e Pediatriche, Università di Torino, 10126 Torino, Italy

Received 12 January 2015; Accepted 9 March 2015

Academic Editor: Elzbieta Kolaczkowska

Copyright © 2015 Giulia Rossana Gulino et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Medzhitov, “Origin and physiological roles of inflammation,” Nature, vol. 454, no. 7203, pp. 428–435, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Nathan, “Points of control in inflammation,” Nature, vol. 420, no. 6917, pp. 846–852, 2002. View at Publisher · View at Google Scholar · View at Scopus
  3. P. Italiani and D. Boraschi, “From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation,” Frontiers in Immunology, vol. 5, article 514, 2014. View at Publisher · View at Google Scholar
  4. R. E. Vandenbroucke and C. Libert, “Is there new hope for therapeutic matrix metalloproteinase inhibition?” Nature Reviews Drug Discovery, vol. 13, no. 12, pp. 904–927, 2014. View at Publisher · View at Google Scholar
  5. B. Cauwe, P. E. Van den Steen, and G. Opdenakker, “The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases,” Critical Reviews in Biochemistry and Molecular Biology, vol. 42, no. 3, pp. 113–185, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Dufour and C. M. Overall, “Missing the target: Matrix metalloproteinase antitargets in inflammation and cancer,” Trends in Pharmacological Sciences, vol. 34, no. 4, pp. 233–242, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. I. Papandreou, A. Powell, A. L. Lim, and N. Denko, “Cellular reaction to hypoxia: sensing and responding to an adverse environment,” Mutation Research—Fundamental and Molecular Mechanisms of Mutagenesis, vol. 569, no. 1-2, pp. 87–100, 2005. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Murdoch, M. Muthana, and C. E. Lewis, “Hypoxia regulates macrophage functions in inflammation,” The Journal of Immunology, vol. 175, no. 10, pp. 6257–6263, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Murdoch, A. Giannoudis, and C. E. Lewis, “Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues,” Blood, vol. 104, no. 8, pp. 2224–2234, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. S. Lewis, J. A. Lee, J. C. E. Underwood, A. L. Harris, and C. E. Lewis, “Macrophage responses to hypoxia: Relevance to disease mechanisms,” Journal of Leukocyte Biology, vol. 66, no. 6, pp. 889–900, 1999. View at Google Scholar · View at Scopus
  11. P. Cabrales and M. Intaglietta, “Blood substitutes: evolution from noncarrying to oxygen- and gas-carrying fluids,” ASAIO Journal, vol. 59, no. 4, pp. 337–354, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. C. L. Modery-Pawlowski, L. L. Tian, V. Pan, and A. Sen Gupta, “Synthetic approaches to RBC mimicry and oxygen carrier systems,” Biomacromolecules, vol. 14, no. 4, pp. 939–948, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. C. I. Castro and J. C. Briceno, “Perfluorocarbon-based oxygen carriers: review of products and trials,” Artificial Organs, vol. 34, no. 8, pp. 622–634, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Cavalli, A. Bisazza, A. Rolfo et al., “Ultrasound-mediated oxygen delivery from chitosan nanobubbles,” International Journal of Pharmaceutics, vol. 378, no. 1-2, pp. 215–217, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Cavalli, A. Bisazza, P. Giustetto et al., “Preparation and characterization of dextran nanobubbles for oxygen delivery,” International Journal of Pharmaceutics, vol. 381, no. 2, pp. 160–165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. C. Magnetto, M. Prato, A. Khadjavi et al., “Ultrasound-activated decafluoropentane-cored and chitosan-shelled nanodroplets for oxygen delivery to hypoxic cutaneous tissues,” RSC Advances, vol. 4, no. 72, pp. 38433–38441, 2014. View at Publisher · View at Google Scholar
  17. M. Prato, C. Magnetto, J. Jose et al., “2H,3H-decafluoropentane-based nanodroplets: new perspectives for oxygen delivery to hypoxic cutaneous tissues,” PLoS ONE, vol. 10, no. 3, Article ID e0119769, 2015. View at Publisher · View at Google Scholar
  18. A. Sze, D. Erickson, L. Ren, and D. Li, “Zeta-potential measurement using the Smoluchowski equation and the slope of the current-time relationship in electroosmotic flow,” Journal of Colloid and Interface Science, vol. 261, no. 2, pp. 402–410, 2003. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Polimeni, E. Valente, E. Aldieri, A. Khadjavi, G. Giribaldi, and M. Prato, “Role of 15-hydroxyeicosatetraenoic acid in hemozoin-induced lysozyme release from human adherent monocytes,” BioFactors, vol. 39, no. 3, pp. 304–314, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Polimeni, E. Valente, E. Aldieri, A. Khadjavi, G. Giribaldi, and M. Prato, “Haemozoin induces early cytokine-mediated lysozyme release from human monocytes through p38 MAPK- and NF-kappaB- dependent mechanisms,” PLoS ONE, vol. 7, no. 6, Article ID e39497, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Polimeni, E. Valente, D. Ulliers et al., “Natural haemozoin induces expression and release of human monocyte tissue inhibitor of metalloproteinase-1,” PLoS ONE, vol. 8, no. 8, Article ID e71468, 2013. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Khadjavi, E. Valente, G. Giribaldi, and M. Prato, “Involvement of p38 MAPK in haemozoin-dependent MMP-9 enhancement in human monocytes,” Cell Biochemistry and Function, vol. 32, no. 1, pp. 5–15, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Cumming, F. Fidler, and D. L. Vaux, “Error bars in experimental biology,” The Journal of Cell Biology, vol. 177, no. 1, pp. 7–11, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. Y. Zhang, K. McCluskey, K. Fujii, and L. M. Wahl, “Differential regulation of monocyte matrix metalloproteinase and TIMP-1 production by TNF-alpha, granulocyte-macrophage CSF, and IL-1beta through prostaglandin-dependent and -independent mechanisms,” Journal of Immunology, vol. 161, no. 6, pp. 3071–3076, 1998. View at Google Scholar · View at Scopus
  25. A. Bar-Or, R. K. Nuttall, M. Duddy et al., “Analyses of all matrix metalloproteinase members in leukocytes emphasize monocytes as major inflammatory mediators in multiple sclerosis,” Brain, vol. 126, no. 12, pp. 2738–2749, 2003. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Ichiyama, M. Kajimoto, M. Hasegawa, K. Hashimoto, T. Matsubara, and S. Furukawa, “Cysteinyl leukotrienes enhance tumour necrosis factor-α-induced matrix metalloproteinase-9 in human monocytes/macrophages,” Clinical and Experimental Allergy, vol. 37, no. 4, pp. 608–614, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Uzui, S. K. Sinha, and T. B. Rajavashisth, “17β-estradiol inhibits oxidized low-density lipoprotein-induced increase in matrix metalloproteinase-9 expression in human macrophages,” Journal of Investigative Medicine, vol. 59, no. 7, pp. 1104–1108, 2011. View at Google Scholar · View at Scopus
  28. M. A. Rahat, B. Marom, H. Bitterman, L. Weiss-Cerem, A. Kinarty, and N. Lahat, “Hypoxia reduces the output of matrix metalloproteinase-9 (MMP-9) in monocytes by inhibiting its secretion and elevating membranal association,” Journal of Leukocyte Biology, vol. 79, no. 4, pp. 706–718, 2006. View at Publisher · View at Google Scholar · View at Scopus
  29. N. Lahat, H. Bitterman, M. Engelmayer-Goren, D. Rosenzweig, L. Weiss-Cerem, and M. A. Rahat, “Reduced TIMP-2 in hypoxia enhances angiogenesis,” The American Journal of Physiology—Cell Physiology, vol. 300, no. 3, pp. C557–C566, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. M. Cote, P. G. A. Rogueda, and P. C. Griffiths, “Effect of molecular weight and end-group nature on the solubility of ethylene oxide oligomers in 2H, 3H-decafluoropentane and its fully fluorinated analogue, perfluoropentane,” Journal of Pharmacy and Pharmacology, vol. 60, no. 5, pp. 593–599, 2008. View at Publisher · View at Google Scholar · View at Scopus
  31. J. G. Riess and M. P. Krafft, “Fluorocarbons and fluorosurfactants for in vivo oxygen transport (blood substitutes), imaging, and drug delivery,” Materials Research Society Bulletin, vol. 24, no. 5, pp. 42–48, 1999. View at Publisher · View at Google Scholar · View at Scopus
  32. E. G. Schutt, D. H. Klein, R. M. Mattrey, and J. G. Riess, “Injectable microbubbles as contrast agents for diagnostic ultrasound imaging: the key role of perfluorochemicals,” Angewandte Chemie—International Edition, vol. 42, no. 28, pp. 3218–3235, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. G. W. Bos, W. E. Hennink, L. A. Brouwer et al., “Tissue reactions of in situ formed dextran hydrogels crosslinked by stereocomplex formation after subcutaneous implantation in rats,” Biomaterials, vol. 26, no. 18, pp. 3901–3909, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. C. J. De Groot, M. J. A. Van Luyn, W. N. E. Van Dijk-Wolthuis et al., “In vitro biocompatibility of biodegradable dextran-based hydrogels tested with human fibroblasts,” Biomaterials, vol. 22, no. 11, pp. 1197–1203, 2001. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Möller, J. Weisser, S. Bischoff, and M. Schnabelrauch, “Dextran and hyaluronan methacrylate based hydrogels as matrices for soft tissue reconstruction,” Biomolecular Engineering, vol. 24, no. 5, pp. 496–504, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Khadjavi, C. Magnetto, A. Panariti et al., “Chitosan-shelled oxygen-loaded nanodroplets abrogate hypoxia dysregulation of human keratinocyte gelatinases and inhibitors: new perspectives for chronic wound healing,” Toxicology and Applied Pharmacology. In press.
  37. S. A. Eming, P. Martin, and M. Tomic-Canic, “Wound repair and regeneration: mechanisms, signaling, and translation,” Science Translational Medicine, vol. 6, no. 265, Article ID 265sr6, 2014. View at Publisher · View at Google Scholar